Compounded Semaglutide vs Brand-Name Ozempic: Why It Matters in South Africa

South African patients researching weight loss medications increasingly come across two paths: brand-name SAHPRA-registered products (Ozempic, Mounjaro, Wegovy, Saxenda) — and compounded semaglutide sold by some pharmacies, "wellness clinics," and online sellers at significantly lower prices. The pricing difference is real. So is the safety difference. Here's what every patient needs to know before making this choice.

What Is Compounded Semaglutide?

Compounding is the legitimate pharmaceutical practice of preparing a customised medication for an individual patient (e.g. an allergy-free formulation of a particular medicine). It is regulated and has appropriate uses.

Compounded semaglutide, however, refers to compounding pharmacies producing their own semaglutide injections — usually using semaglutide base obtained from unregulated international suppliers. These products are sold as a cheaper alternative to brand-name Ozempic or Wegovy. They are not SAHPRA-registered and have not been evaluated for safety, sterility, dose accuracy, or efficacy.

Brand-Name vs Compounded — Side by Side

Why Is Compounded Semaglutide Cheaper?

The price gap reflects what's missing — not what's "saved":

• No regulatory oversight cost. SAHPRA registration requires extensive clinical, manufacturing, and quality data — all expensive.
• Lower-cost active ingredient sources. The semaglutide base often comes from suppliers that don't meet pharmaceutical-grade specifications.
• No clinical trials. Brand-name Wegovy required tens of thousands of patients across the STEP programme. Compounded products inherit no equivalent evidence.
• No cold-chain compliance audits. Storage and transport requirements for semaglutide are strict — compounded products often skip this.
• No post-market surveillance. When something goes wrong, there's no system to detect it.

Real Safety Incidents Reported Internationally

Globally documented harms from compounded GLP-1 products include:

• Overdosing. Patients have been hospitalised after self-injecting from multi-dose vials with confusing labelling — some 10× the intended dose.
• Bacterial contamination. Non-sterile preparation has caused injection-site infections.
• Wrong active ingredient. Some "semaglutide" products tested have contained semaglutide salts (e.g. semaglutide sodium) that are not the same as the FDA/SAHPRA-registered semaglutide base — efficacy and safety unknown.
• Counterfeit pens. Counterfeit Ozempic pens (no actual semaglutide, or wrong drug entirely) have been seized in multiple countries — sometimes containing only insulin, which is dangerous in non-diabetic patients.

SAHPRA's Position

"But What About Generic Versions?"

There are no SAHPRA-registered generic versions of semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro) in South Africa as of 2026. The original patents are still held by Novo Nordisk and Eli Lilly. Any product claiming to be a "generic Ozempic" — South African or imported — is either:

• A compounded preparation (not SAHPRA-approved), OR
• An unauthorised import (illegal), OR
• A counterfeit (criminal)

Once patents expire (estimated 2031–2033 in most jurisdictions), legitimate SAHPRA-registered generics may become available. Until then, brand-name is the only safe option.

How to Verify You're Getting Genuine Medication

1. Always have a valid prescription from a HPCSA-registered doctor.
2. Buy only from licensed pharmacies. Major SA pharmacy chains (Clicks, Dis-Chem, Alpha Pharm, etc.) and licensed independents.
3. Check the packaging. Genuine Ozempic comes in a Novo Nordisk box with hologram, batch number, and tamper-evident seal. Mounjaro comes in an Eli Lilly box with similar security features.
4. Confirm cold-chain handling. Pens should arrive cold and have been stored refrigerated. If a "pharmacy" delivers it at room temperature in a regular envelope, it's not legitimate.
5. Avoid these red flags: No prescription required, social media sellers, suspiciously low prices, "imported direct from manufacturer" with no SA pharmacy involvement, vials instead of pens (the brand products are pen-only in SA).

The Cost Argument — Is It Really Worth It?

The savings are real — but the trade-off is the entire safety, quality, and regulatory framework that exists to protect you. A single hospital admission from a contaminated injection costs more than a year of brand-name treatment.